AdvaMed, the MedTech Association, released its AI Policy Roadmap (the Roadmap) outlining policy priorities for Congress and the U.S. Food and Drug Administration (FDA).

WASHINGTON — FDA Commissioner Martin Makary offered more details into the agency’s recently announced plans to place ...

Stuart J. Schnitt, MD, discussed how AI enhances cancer diagnoses and the need for professional oversight, ethical clarity, ...

CMS and ASTP, the health department’s health IT regulator, released a request for information this week about existing ...

However, trust gaps among clinicians and patients are threatening to slow the adoption and impact of AI. Among HCPs, ...

AI adoption in pharma can be slow, but failing to scale these new tools across your organization is a missed opportunity.